Published in Cardiovasc Res on April 01, 2000
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Sodium channel mutations and arrhythmias. Nat Rev Cardiol (2009) 2.01
Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol (2012) 1.97
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels. Am J Physiol Heart Circ Physiol (2010) 1.66
Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current. Proc Natl Acad Sci U S A (2012) 1.26
The cardiac persistent sodium current: an appealing therapeutic target? Br J Pharmacol (2007) 1.23
A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm (2010) 1.10
Brugada syndrome: from cell to bedside. Curr Probl Cardiol (2005) 1.08
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int J Cardiol (2014) 1.04
Calcium-mediated dual-mode regulation of cardiac sodium channel gating. Circ Res (2009) 1.00
Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can J Cardiol (2006) 0.99
A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. J Med Genet (2006) 0.98
Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13. Mamm Genome (2004) 0.94
The β1-subunit of Na(v)1.5 cardiac sodium channel is required for a dominant negative effect through α-α interaction. PLoS One (2012) 0.89
Structural effects of an LQT-3 mutation on heart Na+ channel gating. Biophys J (2004) 0.88
Altered sinoatrial node function and intra-atrial conduction in murine gain-of-function Scn5a+/ΔKPQ hearts suggest an overlap syndrome. Am J Physiol Heart Circ Physiol (2012) 0.86
Gating pore currents are defects in common with two Nav1.5 mutations in patients with mixed arrhythmias and dilated cardiomyopathy. J Gen Physiol (2015) 0.86
Sodium current reduction unmasks a structure-dependent substrate for arrhythmogenesis in the normal ventricles. PLoS One (2014) 0.82
Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations. Front Pharmacol (2012) 0.82
Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect. J Am Heart Assoc (2016) 0.81
Embryonic type Na(+) channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome. Sci Rep (2016) 0.81
The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome. Medicine (Baltimore) (2016) 0.80
Computational analysis of the human sinus node action potential: model development and effects of mutations. J Physiol (2017) 0.80
Genetic analysis of Brugada syndrome and congenital long-QT syndrome type 3 in the Chinese. J Cardiovasc Dis Res (2010) 0.79
Sodium channel carboxyl-terminal residue regulates fast inactivation. J Biol Chem (2010) 0.78
Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis. PLoS One (2015) 0.77
Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison. Front Pharmacol (2016) 0.76
Mutations in the Voltage Sensors of Domains I and II of Nav1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents. Front Pharmacol (2015) 0.76
Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances. J Interv Card Electrophysiol (2013) 0.76
What we can learn from individual resuscitated patients. Cardiovasc Res (2000) 0.75
Brugada pattern electrocardiogram unmasked with cocaine ingestion. Case Rep Cardiol (2013) 0.75
Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis. Brain (2016) 0.75
Depolarization of the conductance-voltage relationship in the NaV1.5 mutant, E1784K, is due to altered fast inactivation. PLoS One (2017) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation (1995) 4.19
Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A (1992) 3.97
A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet (1997) 3.79
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation (1997) 1.76
Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome. Circ Res (1999) 1.70
Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet (1993) 1.58
Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet (2001) 1.56
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J (1997) 1.55
Tissue Doppler echocardiography in patients with long QT syndrome. Eur J Echocardiogr (2003) 1.49
Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res (2001) 1.44
Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc Res (2000) 1.42
The distinct HERG missense mutation L564P causes long QT syndrome in one French Canadian family. Can J Cardiol (2000) 1.42
Molecular basis of familial cardiomyopathies. Circulation (1995) 1.36
Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol (2004) 1.29
Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am J Hum Genet (1998) 1.29
Clinical and histologic findings in autosomal centronuclear myopathy. Neurology (2004) 1.28
Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels. J Physiol (2002) 1.28
C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation (1999) 1.26
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol Appl Neurobiol (2011) 1.22
Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channels. J Neurosci (2001) 1.19
Chimeric study of sodium channels from rat skeletal and cardiac muscle. FEBS Lett (1992) 1.16
Paroxysmal vagal overactivity, apparent life-threatening event and sudden infant death. Biol Neonate (2000) 1.15
Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res (2001) 1.14
Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. FEBS Lett (2000) 1.11
Exclusion of HRAS from long QT locus. Nat Genet (1994) 1.11
SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells. FEBS Lett (2000) 1.11
Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J (2004) 1.11
Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry (2005) 1.10
Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet (2007) 1.08
Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol (1998) 1.07
Effects of Tityus serrulatus scorpion toxin gamma on voltage-gated Na+ channels. Circ Res (1997) 1.06
The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol (1997) 1.05
Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet (1994) 1.04
Implication of the C-terminal region of the alpha-subunit of voltage-gated sodium channels in fast inactivation. J Membr Biol (2001) 1.03
Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation (1999) 1.00
Multi-minicore disease--searching for boundaries: phenotype analysis of 38 cases. Ann Neurol (2000) 0.98
Two patients with 'Dropped head syndrome' due to mutations in LMNA or SEPN1 genes. Neuromuscul Disord (2005) 0.98
New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation. Neurology (2007) 0.97
Ca2+ oscillations induced by histamine H1 receptor stimulation in HeLa cells: Fura-2 and patch clamp analysis. Cell Calcium (1991) 0.96
Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet (1996) 0.96
Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem (2001) 0.96
Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature. Clin Neuropathol (2009) 0.96
[Congenital long QT syndrome. The value of genetics in prognostic evaluation]. Arch Mal Coeur Vaiss (1999) 0.95
A cellular automata model of the heart and its coupling with a qualitative model. Comput Biomed Res (1996) 0.94
[Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis]. Rev Neurol (Paris) (1996) 0.94
Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther (1999) 0.93
Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet (1998) 0.93
A complication of pacemaker lead extraction: paradoxical embolism of a lead fragment in a leg artery. Pacing Clin Electrophysiol (1998) 0.93
Ehlers-Danlos syndrome due to tenascin-X deficiency: muscle weakness and contractures support overlap with collagen VI myopathies. Am J Med Genet A (2007) 0.92
Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. Eur Heart J (1998) 0.91
Double action of nicardipine on serotonin release from rat platelets. J Cardiovasc Pharmacol (1987) 0.91
A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol (1996) 0.91
Penetrance of familial hypertrophic cardiomyopathy. Genet Couns (1997) 0.91
An interactive qualitative model in cardiology. Comput Biomed Res (1995) 0.91
Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci. Neuropediatrics (2004) 0.91
Mild muscular dystrophy due to a nonsense mutation in the LAMA2 gene resulting in exon skipping. Brain (2001) 0.91
Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype. Neuromuscul Disord (2009) 0.90
[Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the alphaB-cristallin gene]. Rev Neurol (Paris) (2000) 0.90
A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation. Neurology (2009) 0.89
[Long QT syndrome under cisapride in neonates and infants]. Arch Pediatr (1997) 0.89
Closing and inactivation potentiate the cocaethylene inhibition of cardiac sodium channels by distinct mechanisms. Mol Pharmacol (2003) 0.88
Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations. Circulation (2001) 0.88
Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy. J Med Genet (1997) 0.88
Phenylephrine, vasopressin and angiotensin II as determinants of proto-oncogene and heat-shock protein gene expression in adult rat heart and aorta. J Hypertens (1989) 0.88
Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet (1999) 0.87
Biochemical evidence for presynaptic and postsynaptic alpha-adrenoceptors in rat heart membranes: positive homotropic cooperativity of presynaptic binding. Proc Natl Acad Sci U S A (1978) 0.87
Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart (2005) 0.87
Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern. Neuromuscul Disord (2010) 0.86
Diagnostic performance of QT interval variables from 24-h electrocardiography in the long QT syndrome. Eur Heart J (1998) 0.86
Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome. J Mol Cell Cardiol (1996) 0.86